Author

Jean‐Claude Besnard

Observed names: J -C. Besnard, J C Besnard, J. -C. BESNARD, J. -C. Besnard, J. C. BESNARD, J. C. Besnard, J.-C Besnard, J.-C. Besnard, J.C Besnard, J.C. Besnard, J.‐C. BESNARD, J.‐C. Besnard, Jean-Claude Besnard, Jean-Claude Besnard,

Institutions: Centre Hospitalier Universitaire de Tours, Hôpital Bretonneau

Observed institutions: Université de Tours, Karolinska University Hospital, Inserm, Centre Hospitalier Universitaire de Tours, Hôpital Bretonneau, National Institute of Mental Health

OpenAlex ID: A5111674863

α‐Linolenic Acid Dietary Deficiency Alters Age‐Related Changes of Dopaminergic and Serotoninergic Neurotransmission in the Rat Frontal Cortex

1996 · Sylvie Delion, Sylvie Chalon, et al. · Journal of Neurochemistry · 336

Chronic Dietary α-Linolenic Acid Deficiency Alters Dopaminergic and Serotoninergic Neurotransmission in Rats ,

1994 · Sylvie Delion, Sylvie Chalon, et al. · Journal of Nutrition · 316

Dietary Fish Oil Affects Monoaminergic Neurotransmission and Behavior in Rats

1998 · Sylvie Chalon, Sylvie Delion-Vancassel, et al. · Journal of Nutrition · 286

PDF

Serotoninergic neurotransmission is affected by n‐3 polyunsaturated fatty acids in the rat

2004 · Ercem Kodas, Laurent Galineau, et al. · Journal of Neurochemistry · 244

Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n–3 polyunsaturated fatty acids

2000 · Luc Zimmer, Sylvie Delion-Vancassel, et al. · Journal of Lipid Research · 214

Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease

2008 · Gaëlle Bouchez, Luc Sensebé, et al. · Neurochemistry International · 163

Visualization of the Dopamine Transporter in the Human Brain Postmortem with the New Selective Ligand [125I]PE2I

1999 · H. Hall, C. Halldin, et al. · NeuroImage · 135

Synthesis and Ligand Binding of Nortropane Derivatives: N-Substituted 2β-Carbomethoxy-3β-(4‘-iodophenyl)nortropane and N-(3-Iodoprop-(2E)-enyl)-2β-carbomethoxy-3β-(3‘,4‘-disubstituted phenyl)nortropane. New High-Affinity and Selective Compounds for the Dopamine Transporter

1997 · Patrick Emond, Lucette Garreau, et al. · Journal of Medicinal Chemistry · 132

1997 · S Delion, S Chalon, et al. · Journal of Lipid Research · 124

Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study

1998 · L Zimmer, S Hembert, et al. · Neuroscience Letters · 120

Exploration of the Dopamine Transporter: In Vitro and In Vivo Characterization of a High-Affinity and High-Specificity Iodinated Tropane Derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy- 3β-(4′-methylphenyl)nortropane (PE2I)

1998 · Denis Guilloteau, Patrick Emond, et al. · Nuclear Medicine and Biology · 71

Diagnosis of Medullary Carcinoma of the Thyroid (MCT) by Calcitonin Assay Using Monoclonal Antibodies: Criteria for the Pentagastrin Stimulation Test in Hereditary MCT

1990 · D. GUILLOTEAU, R. PERDRISOT, et al. · The Journal of Clinical Endocrinology & Metabolism · 66

Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n ortropane as a selective and potent inhibitor of the neuronal dopamine transporter.

1999 · S Chalon, L Garreau, et al. · PubMed · 58

Pharmacological Characterization of N,N-Dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a Ligand of the Serotonin Transporter with High Affinity and Selectivity

2003 · Sylvie Chalon, Jari Tarkiainen, et al. · Journal of Pharmacology and Experimental Therapeutics · 56

Skeletal uptake of pyrophosphate labeled with technetium-95m and technetium-96, as evaluated by autoradiography.

1978 · A Guillemart, J C Besnard, et al. · PubMed · 43

Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease

1999 · Sylvie Chalon, Patrick Emond, et al. · Synapse · 41

Comparison of MIBG and monoamines uptake mechanisms: Pharmacological animal and blood platelets studies

1988 · D. Guilloteau, S. Chalon, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 41

Pharmacological Characterization of (E)-N-(4-Fluorobut-2-enyl)-2β-carbomethoxy-3β-(4′-tolyl)nortropane (LBT-999) as a Highly Promising Fluorinated Ligand for the Dopamine Transporter

2006 · Sylvie Chalon, Hakan Hall, et al. · Journal of Pharmacology and Experimental Therapeutics · 39

Presymptomatic diagnosis of experimental Parkinsonism with 123I-PE2I SPECT

2003 · Caroline Prunier, Erwan Bézard, et al. · NeuroImage · 38

Pharmacological Characterization of (E)-N-(3-iodoprop-2-enyl)-2β-Carbomethoxy-3β-(4′-methylphenyl)nortropane as a Selective and Potent Inhibitor of the Neuronal Dopamine Transporter

1999 · Sylvie Chalon, Lucette Garreau, et al. · Journal of Pharmacology and Experimental Therapeutics · 38

Substituted Diphenyl Sulfides as Selective Serotonin Transporter Ligands: Synthesis and In Vitro Evaluation

2002 · Patrick Emond, Johnny Vercouillie, et al. · Journal of Medicinal Chemistry · 37

Estrogen receptor imaging with 17α-[123I]iodovinyl-11β-methoxyestradiol (MIVE2)—part II. Preliminary results in patients with breast carcinoma

1992 · M.J. Ribeiro-Barras, C. Foulon, et al. · International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology · 31

PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter

1999 · Julie Helfenbein, Johan Sandell, et al. · Nuclear Medicine and Biology · 28

Therapeutic effectiveness of iodine-131 MIBG metastases of a nonsecreting paraganglioma.

1988 · J L Baulieu, D Guilloteau, et al. · PubMed · 28

Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide

2000 · Christelle Gouhier, Sylvie Chalon, et al. · Neuroscience Letters · 26

Works count: 90

Citation count: 3,100

H-index: 25

I10-index: 39